UBE2M and cancer: Several approaches, including Ubc12 knockdown, the overexpression of dominant-negative Ubc12 and chemical inhibitors of the Ubc12-DCN1 interaction, have been used to understand the cellular functions of Ubc12 in cancer cells and the selective effects on cullin–RING ligase substrates (26–30).